Clinical Trial Update: A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human Phase 1/2 study evaluating the safety and tolerability of AZD8853 in selected advanced/metastatic solid tumors (urinary bladder neoplasms, colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Urinary Bladder Neoplasms

Drugs mentioned

• AZD8853

Snippet

Sponsor: AstraZeneca | Conditions: Urinary Bladder Neoplasms, Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-10-01